Squarepoint
MDXH icon

Squarepoint’s MDxHealth MDXH Stock Holding History

Squarepoint’s Portfolio MDXH Stock Details MDXH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$82.2K Buy
+200,281
New +$269K ﹤0.01% 4226
2026
Q1 		– Sell
-14,341
Closed -$51.2K – 4682
2025
Q4 		$51.2K Buy
+14,341
New +$56.7K ﹤0.01% 4128

Other funds holding MDXH

BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $1.91M AUM 81.42% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Squarepoint's MDXH Position: Q2 2026 in Review

Squarepoint opened a new position in MDxHealth (MDXH) in Q2 2026: 200,281 shares worth $82.2K. The stake represents ﹤0.01% of the portfolio and ranks #4226 among its holdings. This is a return to the name: Squarepoint previously reported a position in MDXH as recently as Q4 2025.

Squarepoint first reported a position in MDXH in Q4 2025 and has held it in 2 quarters since. 26 funds tracked by Wall St. Rank hold MDXH as of Q2 2026.

  • Squarepoint held 200,281 shares of MDxHealth worth $82.2K as of Q2 2026.
  • MDxHealth was a new Squarepoint position in Q2 2026.
  • MDxHealth made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #4226 holding.
  • Squarepoint first reported a position in MDxHealth in Q4 2025 and has held it in 2 quarters since.
  • 26 funds tracked by Wall St. Rank held MDxHealth as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.